Bright Minds Biosciences Inc.DRUG
Key ratios
ROA
-18.8%2025
2024
-25.3%2023
-47.5%
ROE
-27.9%2025
2024
-46.2%2023
-86.0%
Recent news
Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
Track DRUG in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer